Many professional organizations publish clinical practice guidelines for the use of probiotics in gastrointestinal disorders. Generally, no two guidelines align perfectly, and some differ markedly. These discrepancies occur because clinical practice guidelines are not purely mechanical outputs of data synthesis. They are shaped by structured interpretation, value judgments, and predefined thresholds for uncertainty. These elements become particularly visible when effect sizes are small, heterogeneity is high, and outcomes vary in clinical relevance-as is the case with probiotic research. This article examines why discordance among probiotic guidelines is predictable and provides practical guidance for clinicians who must decide among conflicting recommendations to make the most appropriate management decisions for their patients. Guidance is also provided for investigators who seek to improve the quality of evidence, confidence in recommendations, and accurate communication of probiotic research to clinicians, patients, and the broader scientific ecosystem.
Preidis et al. (Wed,) studied this question.